Beta blocking agents and antithyroid drugs as adjuncts to radioiodine therapy.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000627:therapeutic use*; D002231:Carbimazole / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000532:radiotherapy*; D007037:Hypothyroidism / Q000209:etiology; D007093:Imidazoles / Q000627:therapeutic use*; D007456:Iodine Isotopes / Q000627:therapeutic use*; D008713:Methimazole / Q000627:therapeutic use; D008779:Methylthiouracil / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications; D010472:Perchlorates / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use; D011193:Potassium Iodide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011441:Propylthiouracil / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000150:complications; D013890:Thiourea / Q000627:therapeutic use; D013974:Thyroxine / Q000097:blood; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D013956:Antithyroid Agents; D007093:Imidazoles; D007456:Iodine Isotopes; D010472:Perchlorates; D011193:Potassium Iodide; D008713:Methimazole; D011441:Propylthiouracil; D002231:Carbimazole; D011433:Propranolol; D013890:Thiourea; D013974:Thyroxine; D008779:Methylthiouracil; D011188:Potassium